| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.29 | 0.1 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.092 | 0.1 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.1 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.086 | 0.1 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.065 | 0.1 |